Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05008536 · UNKNOWN
Trial details
- NCT number
- NCT05008536
- Sponsor
- Xinqiao Hospital of Chongqing
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-09-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.